PROF Stock Analysis: Buy, Sell, or Hold?
PROF - Profound Medical Corp. Common Stock
$6.43
-0.10 (-1.53%)
▼
5d:
+2.06%
30d:
-14.04%
90d:
-18.3%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
PROF is down 25.9% this week, but smart money is accumulating calls. Top strike: $7.5 2026-04-17 with 244 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When PROF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PROF shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PROF shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: PROF is currently trading at $6.43, which is considered fair relative to its 30-day fair value range of $5.35 to $7.12.
Technical Outlook: Technically, PROF is in a downtrend. Immediate support is located at $5.02, while resistance sits at $6.71.
Market Sentiment: PROF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.90 (+85.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PROF is in a downtrend. Immediate support is located at $5.02, while resistance sits at $6.71.
Market Sentiment: PROF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.90 (+85.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$5.35 -
$7.12
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 85.1% below Wall St target ($11.90)
Fair Price Analysis
30-Day Fair Range
$5.35 -
$7.12
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$0.95
(14.8%)
Support & Resistance Levels
Support Level
$5.02
Resistance Level
$6.71
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.20
Wall Street Target
$11.90
(+85.1%)
Revenue Growth (YoY)
43.1%
Profit Margin
-264.4%
Share & Embed Analysis
Last updated: April 03, 2026 1:47 AM ET
Data refreshes hourly during market hours. Next update: 2:47 AM
Data refreshes hourly during market hours. Next update: 2:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PROF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
